Gene mutations impede oocyte maturation, fertilization, and early embryonic development

Area of Science:

• Reproductive Biology
• Human Genetics
• Developmental Biology

Background:

• Reproductive diseases and infertility are increasing globally, affecting 15% of the population, with women disproportionately affected.
• Oocyte maturation, fertilization, and embryo development are critical for successful pregnancy.
• Genetic mutations in developmental regulators are increasingly identified as causes of infertility in young women.

Purpose of the Study:

• To review and categorize clinically identified genetic factors causing infertility.
• To elucidate the molecular mechanisms underlying female infertility due to genetic mutations.
• To compare human and mouse model phenotypes for improved clinical diagnosis and treatment strategies.

Main Methods:

• Literature review and categorization of genetic factors based on molecular characteristics.
• Analysis of mutations in nuclear, cytoplasmic, primate-specific, cell membrane, and zona pellucida factors.
• Comparative analysis of phenotypic discrepancies between human and mouse models.

Main Results:

• Identified and categorized key genetic factors implicated in infertility, including nuclear (e.g., WEE2, CDC20), cytoplasmic (e.g., TLE6, NLRP5), primate-specific (TUBB8), cell membrane (PANX1), and zona pellucida (ZP1-3) factors.
• Highlighted how these genetic mutations can impede oocyte maturation, fertilization, or early embryonic development.
• Observed differences in phenotypes between human and mouse models provide insights into disease mechanisms.

Conclusions:

• Genetic mutations in developmental regulators are significant contributors to female infertility.
• Categorization of these factors aids in understanding their roles and developing targeted diagnostic and therapeutic approaches.
• Comparative studies of human and mouse models are crucial for advancing the clinical management of reproductive diseases.